2013-03-21 08:35:56 -

The shareholders in CellaVision AB are hereby summoned to the Annual General
Meeting, to be held on April 24, 2013 at 16.00 at CellaVision AB, Scheelevägen
19 A, Ideon, in Lund, Sweden.

The complete notice is available in Swedish only, please click the link below.

For more information, please contact:
Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82
e-mail: yvonne.martensson@cellavision.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The products rationalize manual laboratory work,
and secure and support effective workflows and skills development within and
between hospitals. The company has leading-edge expertise in image analysis,
artificial intelligence and automated microscopy. In most countries sales are
via global partners. Products are   sold directly in the Nordic countries and via
subsidiaries in the US, Canada and Japan. In 2012 sales were SEK 170 million and
sales continue to increase, with a growth target of at least 15 % per year over
an economic cycle. CellaVision's registered office is in Lund, Sweden. The share
is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at
www.cellavision.com.


Notice of AGM in CellaVision AB, April 24, 2013 (in Swedish): 
 hugin.info/132164/R/1686769/553046.pdf



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1686769]